Joana Vidal

5PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 11, 2025
Adjuvant Immunotherapy After Resected Melanoma: Survival Outcomes, Prognostic Factors and Patterns of Relapse.

Sergio Martinez-Recio, Maria Alejandra Molina-Pérez, Eva Muñoz-Couselo

|Sep 08, 2022
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study.

Joana Vidal, Maria Concepción Fernández-Rodríguez, David Casadevall

|Jul 02, 2021
ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC).

Laura Masfarré, Joana Vidal, Concepción Fernández-Rodríguez

|Mar 17, 2021
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial.

Joana Vidal, David Casadevall, Beatriz Bellosillo

Pageof 1